Whitehawk Therapeutics (WHWK) Non Operating Income (2016 - 2021)

Whitehawk Therapeutics (WHWK) has 6 years of Non Operating Income data on file, last reported at $363426.0 in Q2 2021.

• On a quarterly basis, Non Operating Income rose 1706.38% year-over-year to $363426.0 in Q2 2021; TTM through Jun 2021 was $1.3 million, a 94.1% increase from a year earlier, with the FY2020 full-year figure at $2.0 million, up 98.06% from the prior year.
• Non Operating Income for Q2 2021 stood at $363426.0, up from $3036.0 in the prior quarter.
• Over the last five years, Non Operating Income for WHWK reached as high as $918953.0 in Q4 2020 and fell as low as -$236118.0 in Q1 2017.
• Historically, Non Operating Income has averaged $187645.4 across 5 years, with a median of $151470.5 in 2017.
• Across the five-year window, Non Operating Income plunged 2297.47% in 2017 and soared 1706.38% in 2021, its largest moves.
• Year by year, Non Operating Income stood at $53829.0 in 2017, then surged by 545.73% to $347588.0 in 2018, then plunged by 39.27% to $211089.0 in 2019, then soared by 335.34% to $918953.0 in 2020, then sank by 60.45% to $363426.0 in 2021.
• Per Business Quant data, the three most recent Non Operating Income figures were $363426.0 in Q2 2021, $3036.0 in Q1 2021, and $918953.0 in Q4 2020.